联泓新科(003022.SZ)拟向科院生物增资1.5亿元

Core Viewpoint - The company is focusing on biodegradable materials as a key strategic development direction, with plans to enhance its subsidiary's financial structure through a capital increase [1] Group 1: Company Strategy - The company plans to invest 150 million yuan in its subsidiary, Jiangxi Academy of Biological New Materials Co., Ltd., to accelerate strategic layout and development [1] - The capital increase aims to supplement the working capital of the subsidiary and improve its asset-liability structure [1] Group 2: Subsidiary Operations - Jiangxi Academy of Biological New Materials Co., Ltd. is primarily engaged in the research, production, and sales of lactic acid and polylactic acid [1] - Other shareholders of the subsidiary will not participate in this capital increase [1]